Stock 301207 HUALAN BIOLOGICAL VACCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hualan Biological Vaccine Inc.

Equities

301207

CNE1000058J9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 30/06/2024 BST 		5-day change 1st Jan Change
17.39 CNY -1.58% Intraday chart for Hualan Biological Vaccine Inc. +1.16% -37.45%
06-07 Hualan Biological Vaccine to Buy Back Up to 200 Million Yuan Worth of Shares MT
06-06 Hualan Biological Vaccine Inc. announces an Equity Buyback for CNY 200 million worth of its shares. CI

Business Summary

Hualan Biological Vaccine Inc, formerly Hualan Biological Bacterin Inc, is a China-based company principally engaged in the research, development, production and sales of human vaccines. The Company's listed products mainly include influenza virus split vaccine, quadrivalent influenza virus split vaccine, influenza A H1N1 split vaccine, recombinant hepatitis B vaccine and others. The Company's products that have been approved for clinical trials or have passed clinical registration and are pending for marketing mainly include human rabies vaccines, adsorbed tetanus vaccines, H7N9 influenza whole virus inactivated vaccines and others. The Company's products in the preclinical research stage include inactivated new coronavirus vaccine, freeze-dried nasal spray recombinant new coronavirus live attenuated vaccine and others.

Number of employees: 770

Sales per Business

CNY in Million2022Weight2023Weight Delta
Influenza Vaccine
99.7 %
1,818 99.6 % 2,403 99.7 % +32.19%
Other
0.3 %
8 0.4 % 8 0.3 % -3.97%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.8 %
1,825 100.0 % 2,407 99.8 % +31.84%
Foreign
0.2 %
0 0.0 % 4 0.2 % +1,737.78%

Managers

Managers TitleAgeSince
Wen Jue An CEO
 Chief Executive Officer 35 28/03/22
Cheng Yu Lü DFI
 Director of Finance/CFO 43 31/05/20
Xiao Feng Cui CTO
 Chief Tech/Sci/R&D Officer 49 31/03/17
Ruo Wen Pan BRD
 Director/Board Member 56 31/05/13
Lun Li IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Kang An CHM
 Chairman 75 31/03/13
Bei Fan BRD
 Director/Board Member 52 31/03/13
Ruo Wen Pan BRD
 Director/Board Member 56 31/05/13
De Xin Li BRD
 Director/Board Member 71 31/05/20
Xiao Wei Ma BRD
 Director/Board Member 56 31/03/13
Chao Yuan Ma BRD
 Director/Board Member 40 31/05/20
Wen Qi An BRD
 Director/Board Member 45 31/05/20
Yuan Cheng Lou CHM
 Chairman 40 31/05/20
Guan Mu Dong BRD
 Director/Board Member 72 02/06/20
Wen Jue An CEO
 Chief Executive Officer 35 28/03/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 600,015,000 84,102,572 ( 14.02 %) 0 14.02 %

Shareholders

NameEquities%Valuation
Hai Yan Zhang
26.07 %
36,767,850 26.07 % 96 M ¥
Zhuhai Gaoling Equity Investment Management Co. Ltd.
25.92 %
36,544,129 25.92 % 95 M ¥
Chenyi Investment Co. Ltd.
22.98 %
32,400,000 22.98 % 84 M ¥
Huatai Hualan Vaccine Home No 1 Gem Esop Asset Mgmt Plan
4.256 %
6,001,500 4.256 % 16 M ¥
Caitong Securities Asset Management Co., Ltd.
1.950 %
2,749,785 1.950 % 7 M ¥
Bosera Asset Management Co., Ltd.
1.586 %
2,236,704 1.586 % 6 M ¥
China Merchants Fund Management Co., Ltd.
1.574 %
2,219,587 1.574 % 6 M ¥
Tian Hong Asset Management Co., Ltd.
1.262 %
1,779,724 1.262 % 5 M ¥
Zhong Ge Kan
0.8374 %
1,180,814 0.8374 % 3 M ¥
Huatai Insurance Group Co., Ltd.
0.6386 %
900,470 0.6386 % 2 M ¥

Company contact information

Hualan Biological Vaccine, Inc.

No. 1, No. 1, Hualan Avenue

453003, Xinxiang

+

http://www.hualanbacterin.com
address Hualan Biological Vaccine Inc.(301207)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Hualan Biological Vaccine Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
17.39 CNY
Average target price
29.3 CNY
Spread / Average Target
+68.49%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
HUALAN BIOLOGICAL VACCINE INC. Stock Hualan Biological Vaccine Inc.
-37.45% 1.44B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-0.13% 39.05B
BIOGEN INC. Stock Biogen Inc.
-10.43% 33.74B
UCB Stock UCB
+78.33% 28.54B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.82% 15.59B
INCYTE CORPORATION Stock Incyte Corporation
-3.06% 13.69B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.76% 11.44B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+181.73% 10.66B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-53.92% 9.27B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.69% 9.13B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 301207 Stock
  4. Company Hualan Biological Vaccine Inc.